Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells

被引:0
作者
Xinjian Liu
Fang Li
Elizabeth A Stubblefield
Barbara Blanchard
Toni L Richards
Gaynor A Larson
Yujun He
Qian Huang
Aik-Choon Tan
Dabing Zhang
Timothy A Benke
John R Sladek
Nancy R Zahniser
Chuan-Yuan Li
机构
[1] University of Colorado School of Medicine,Departments of Radiation Oncology
[2] Shanghai First People's Hospital,Department of Pharmacology
[3] School of Medicine,Department of Neurology
[4] Shanghai Jiaotong University,Department of Pediatrics
[5] University of Colorado School of Medicine,Current address: Department of Dermatology
[6] University of Colorado School of Medicine,undefined
[7] Third Military Medical University,undefined
[8] School of Life Science and Biotechnology,undefined
[9] Shanghai Jiaotong University,undefined
[10] University of Colorado School of Medicine,undefined
[11] Charles Gates Center for Stem Cell and Regenerative Medicine,undefined
[12] University of Colorado School of Medicine,undefined
[13] Box 3135,undefined
[14] Duke University Medical Center,undefined
[15] Durham,undefined
[16] NC 27710,undefined
[17] USA,undefined
来源
Cell Research | 2012年 / 22卷
关键词
direct reprogramming; dopaminergic neurons; fibroblast; Parkinson's disease;
D O I
暂无
中图分类号
学科分类号
摘要
Transplantation of exogenous dopaminergic neuron (DA neurons) is a promising approach for treating Parkinson's disease (PD). However, a major stumbling block has been the lack of a reliable source of donor DA neurons. Here we show that a combination of five transcriptional factors Mash1, Ngn2, Sox2, Nurr1, and Pitx3 can directly and effectively reprogram human fibroblasts into DA neuron-like cells. The reprogrammed cells stained positive for various markers for DA neurons. They also showed characteristic DA uptake and production properties. Moreover, they exhibited DA neuron-specific electrophysiological profiles. Finally, they provided symptomatic relief in a rat PD model. Therefore, our directly reprogrammed DA neuron-like cells are a promising source of cell-replacement therapy for PD.
引用
收藏
页码:321 / 332
页数:11
相关论文
共 128 条
[1]  
Bezard E(2001)Pathophysiology of levodopa-induced dyskinesia: potential for new therapies Nat Rev Neurosci 2 577-588
[2]  
Brotchie JM(2008)Molecular mechanisms of L-DOPA-induced dyskinesia Nat Rev Neurosci 9 665-677
[3]  
Gross CE(2010)Parkinson disease: deep brain stimulation versus best medical therapy for PD Nat Rev Neurol 6 530-532
[4]  
Jenner P(1987)Transplantation of fetal dopamine neurons in primate brain reverses MPTP induced parkinsonism Prog Brain Res 71 309-323
[5]  
Brodsky MA(1990)Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease Science 247 574-577
[6]  
Nutt JG(1992)Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease N Engl J Med 327 1541-1548
[7]  
Sladek JR(1992)Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N Engl J Med 327 1556-1563
[8]  
Redmond DE(1997)Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease Nat Med 3 350-353
[9]  
Collier TJ(2007)Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 861-872
[10]  
Lindvall O(2006)Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 663-676